We are live on ! Find out more
ELAN icon

Elanco Animal Health

402 hedge funds and large institutions have $6.96B invested in Elanco Animal Health in 2024 Q2 according to their latest regulatory filings, with 77 funds opening new positions, 138 increasing their positions, 123 reducing their positions, and 45 closing their positions.

New
Increased
Maintained
Reduced
Closed

229% more call options, than puts

Call options by funds: $70.2M | Put options by funds: $21.3M

71% more first-time investments, than exits

New positions opened: 77 | Existing positions closed: 45

12% more repeat investments, than reductions

Existing positions increased: 138 | Existing positions reduced: 123

7% more funds holding

Funds holding: 375402 (+27)

0.01% more ownership

Funds ownership: 97.69%97.7% (+0.01%)

11% less capital invested

Capital invested by funds: $7.83B → $6.96B (-$868M)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

Holders
402
Holders Change
+27
Holders Change %
+7.2%
% of All Funds
5.81%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
77
Increased
138
Reduced
123
Closed
45
Calls
$70.2M
Puts
$21.3M
Net Calls
+$48.8M
Net Calls Change
-$2.55M
Name Holding Trade Value Shares
Change
Change in
Stake
OAM
251
Oppenheimer Asset Management
New York
$264K +$98.9K +6,191 +51%
HSBC Holdings
252
HSBC Holdings
United Kingdom
$261K -$11.2M -698,718 -97%
X
253
Xponance
Pennsylvania
$257K -$831 -52 -0.3%
AC
254
ASB Consultores
Florida
$255K -$25.6K -1,600 -8%
HAIM
255
Hunter Associates Investment Management
Pennsylvania
$239K
TSS
256
Two Sigma Securities
New York
$238K +$263K +16,488 New
OAM
257
Oxford Asset Management
United Kingdom
$233K -$267K -16,696 -51%
SS
258
Sunbelt Securities
Texas
$231K
CIBC Asset Management
259
CIBC Asset Management
Ontario, Canada
$224K
FIM
260
Freedom Investment Management
Connecticut
$217K +$241K +15,069 New
SACTSONJ
261
Supplemental Annuity Collective Trust (SACT) of New Jersey
New Jersey
$216K
DTL
262
Dynamic Technology Lab
Singapore
$216K -$134K -8,389 -36%
AC
263
Armistice Capital
New York
$214K -$187K -11,714 -44%
JCM
264
Jag Capital Management
Missouri
$207K +$230K +14,379 New
IC
265
IEQ Capital
California
$204K +$17.3K +1,084 +8%
BL
266
BFSG LLC
California
$203K -$13.1K -819 -6%
VIM
267
VELA Investment Management
Ohio
$197K +$219K +13,683 New
Carson Wealth (CWM LLC)
268
Carson Wealth (CWM LLC)
Nebraska
$192K +$2.99K +187 +1%
OSAM
269
O'Shaughnessy Asset Management
Connecticut
$191K +$212K +13,250 New
NEI
270
Northwest & Ethical Investments
Ontario, Canada
$191K +$101K +6,300 +91%
ProShare Advisors
271
ProShare Advisors
Maryland
$190K -$70.2K -4,396 -25%
FFM
272
Forum Financial Management
Illinois
$189K +$320 +20 +0.2%
HSA
273
HBK Sorce Advisory
Pennsylvania
$186K +$17.7K +1,107 +9%
MIM
274
MTM Investment Management
South Carolina
$186K -$2.4K -150 -1%
Wolverine Trading
275
Wolverine Trading
Illinois
$182K -$349K -21,862 -63%

ELAN Hedge Fund Activity: Q2 2024 in Review

402 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Elanco Animal Health (ELAN) for Q2 2024, worth a combined $6.96B — down 11% from $7.83B a quarter earlier.

Buyers outnumbered sellers: 77 funds opened new ELAN positions and 45 closed out — a net gain of 32 holders — while 138 added to existing stakes and 123 trimmed.

The largest buyer was T. Rowe Price Associates, adding an estimated $94.7M. The largest seller was Ancora Advisors, exiting entirely with an estimated $173M sold.

  • 402 institutional investors held Elanco Animal Health (ELAN) as of Q2 2024, up from 375 in Q1 2024.
  • Funds reported $6.96B of Elanco Animal Health stock for Q2 2024, down 11% quarter-over-quarter.
  • 77 funds opened new Elanco Animal Health positions in Q2 2024 and 45 closed out, a net change of +32 holders.
  • The largest Elanco Animal Health buyer in Q2 2024 was T. Rowe Price Associates, an estimated $94.7M added.
  • The largest Elanco Animal Health seller in Q2 2024 was Ancora Advisors, an estimated $173M sold.

Based on aggregated 13F filings for Q2 2024.